自1978年首位婴儿通过辅助生殖技术（assisted reproductive technology，ART）诞生以来，全球至少有1200万名婴儿通过ART出生。目前，我国每年实施的ART周期数已突破100万，占全球ART周期总数的30%。

Nexpring Health, a global leader in assisted reproductive technology (ART) solutions, today announced a strategic investment in May Health, a medical device company pioneering a novel treatment ...

The global Assisted Reproductive Technology (ART) market is poised for significant growth, with a value of USD 29.59 billion in 2025, projected to reach USD 49.30 billion by 2033 at a 6.59% CAGR. Key ...

BEIJING, March 5 (Xinhua) -- China will enhance childbirth support through various economic and social policies, according to a draft outline of the 15th Five-Year Plan (2026-2030). China is set to ex ...

Consistency in Care and Improved Engagement: Patients benefit from advanced laboratory innovation without added complexity or changes to their care pathway. Patients can receive a video record of ...